Skip to main content

Table 3 The influence of gut–bacteria on the functions of MSCs

From: Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect

Gut bacteria

Source of MSC

Experimental condition

Pathways/secretomes involved

Outcome of interaction

References

Specific-pathogen-free (SPF) gut microbiota

Bone marrow

DSS-induced colitis

Cell metabolic, HIF-1/inflammatory signaling, and neurodegenerative pathways

Altered MSC differentiation potential

Enhanced immunomodulation capacity of MSC

Decreased disease activity index

[67]

Lactobacillus acidophilus

Canine adipose

In vitro

Increased transcription of key immunomodulatory genes, like COX2, IL6 and IL8

Significantly increased PGE2

Enhanced immunoregulatory function

No induction of MSC death, degeneration or diminished proliferation

No effect on MSC migration

[70]

Salmonella typhi

Canine adipose

In vitro

Increased transcription of key immunomodulatory genes like COX2, IL6 and IL8

No induction of antigen-presenting phenotype

Increased capacity of MSCs to inhibit mitogen-induced T-cell proliferation

Induction and expression of PPARγ, IL-6, IL8, HGF, COX2, CD54 and PGE2

Impeded MSC migration

[70]

Restored composition and diversity of gut microbiota with Lactobacillus

Bone marrow

Chronic hypoxic rats

Restored defect of senescence, poor cell proliferation, cell cycle arrest and multi-lineage differentiation deficiency in MSCs

Reduced d-galactose accumulation

[47]

Lactobacillus rhamnosus GG

Lamina propria of the villus

Intestinal radioprotection in vitro

TLR2 and COX-2 dependent induction

Lactobacillus rhamnosus GG produced LTA, which then primed the epithelial stem cell niche to protect epithelial stem cells by activating macrophages and PGE2 secreting MSCs

[76]

Helicobacter pylori

Bone marrow

GIT infection by H. pylori

Over-expression of TNFα and CCL2

TNFα leads to activation of NF-κB-dependent pathway

Stimulated migration of MSC

[77]

  1. This presents a sum-up of documented impacts of gut microbiome including some pathogenic bacteria on the functions of MSCs. In each demonstration, certain functions of MSCs were mostly improved with no distortion to the inherent properties
  2. PPARγ peroxisome proliferator activator receptor gamma, IL interleukin, HGF hepatocyte growth factor, COX2 cyclooxygenase 2, PGE2 prostaglandin 2, NF-κB Nuclear Factor-kappa B, TLR2 toll-like receptor 2, LTA lipoteichoic acid, CCL2 C–C motive Chemokine ligand 2, TNFα tumor necrosis factor α